Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus with Paclitaxel/Bevacizumab in HER2-negative MBC
NCT00915603Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Jul 2009
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus, sponsored by SCRI Development Innovations. Started Jul 2009; status: completed.
02
Drugs
everolimus
Beyond the preview
Go deeper on NCT00915603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00915603.